Company / Cash per Share
Axsome Therapeutics, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$6.64
FY2025
5-year range
$2.30 / $8.88
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
#33 of 205
Health Care
What the data says
Axsome Therapeutics, Inc.'s cash per share of $6.64 is higher than 84% of companies in the Health Care sector (FY2025). Declined from $8.88 to $6.64 over the past 2 years.
Based on SEC 10-K filings.
6.64 in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Declined from $8.88 to $6.64 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 205This company $6.64 Sector average $72.93
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 0.4% year-over-year.
- Ranks #33 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.64 | -0.4% |
| FY2024 | $6.66 | -25.0% |
| FY2023 | $8.88 | +67.2% |
| FY2022 | $5.31 | +131.0% |
| FY2021 | $2.30 | -53.5% |
| FY2020 | $4.94 | -23.6% |
| FY2019 | $6.47 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026